DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Mark Nagel

Mark Nagel

Trudell Medical International

Paper: Importance of the Tongue as an Impactor for Orally Inhaled Aerosols from a Pressurised Metered Dose inhaler (pMDI) With and Without a Valved Holding Chamber (VHC)

Download Paper

Mark is currently the Head of Aerosol Science at Trudell Medical International, a Canadian medical device company specializing in Respiratory Drug Delivery and Airway Clearance. In his 30 years at Trudell he has extensive experience in the design, development, and testing of aerosol drug delivery devices. He has contributed to several regulatory submissions and over 130 publications, many of which have been published in the peer reviewed literature, conference presentations, and conference papers, combined with several patents and applications currently under review.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk